ICT-107 is the company’s dendritic cell based cancer vaccine candidate that targets multiple tumor antigens for the treatment of glioblastoma multiforme (GBM). ImmunoCellular’s double-blind, placebo-controlled, 2:1 randomized Phase
CEQ508 is intended to be used as a treatment for reducing the levels of beta-catenin protein in the epithelial cells of the small and large intestine. In the
AVL-192 is an oral compound that silences the HCV protease (NS3) through irreversible covalent bonding to the target protein. Preclinical data presented by Avila demonstrated that it selectively
As per the agreement, AustarPharma will use its proprietary technologies for developing and manufacturing products for Amerigen to commercialize in the US and other territories. The terms of
Luminex’s xTAG GPP detects hemolytic-uremic syndrome (HUS) causing Shiga-like toxin producing E. coli strain (STEC), besides detecting common disease-causing gastrointestinal pathogens, including viruses, bacteria and parasites, such as
The company plans to recruit around 117 patients in the trial. The primary objective of the trial is to establish the hematologic improvement-erythroid (HI-E) response rate as measured
Strontium-89, an intravenously (IV) administered cancer drug, provides pain relief for patients suffering from bone pain due to metastatic cancer, caused by advanced stage breast, prostate or lung
Aurobindo‘s Alprazolam Extended-Release Tablets 0.5mg, 1mg, 2mg, and 3mg are generic equivalent to Pharmacia and Upjohn’s Xanax XR tablets 0.5mg, 1mg, 2mg, and 3mg. Alprazolam Extended-Release Tablets are
Emtrix exhibits mechanism of action in which visible improvements are seen within 2-4 weeks of treatment. Under the agreement OzHealth Pharma will receive rights to market and sell
The thermal insulation is used in the ultra low temperature Cryometrix T-150 freezers that Reflect Scientific manufactures and sells. Reflect Scientific develops technologies in cryogenic cooling for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.